Nsengimana

MX2 mediates establishment of interferon response profile, regulates XAF1, and can sensitize melanoma cells to targeted therapy

*Cancer Medicine* 2021; doi:10.1002/cam4.3846

Tumour gene expression signature in primary melanoma predicts long-term outcomes

*Nature Communications* 2021; 12:1137

The role of CAF derived exosomal microRNAs in the tumour microenvironment of melanoma

*Biochimica et Biophysica Acta (BBA) - Reviews on Cancer* 2021; 1875(1):188456

Cell state diversity promotes metastasis through heterotypic cluster formation in melanoma

bioRxiv 2020; DOI:10.1101/2020.08.24.265140

Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis

*Clinical Epigenetics* 2020; 12:127

Study of the female sex survival advantage in melanoma--A focus on X-linked epigenetic regulators and immune responses in two cohorts

*Cancers* 2020; 12(8):2082

Factors affecting sentinel node metastasis in thin (T1) cutaneous melanomas: Development and external validation of a predictive nomogram

*Journal of Clinical Oncology* 2020; 38(14):1591-1601

Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma

*Clinical and Experimental Immunology* 2019; 200(1):33-44

Vitamin D–VDR signaling inhibits Wnt/β-Catenin–mediated melanoma progression and promotes antitumor immunity

*Cancer Research* 2019; 79(23):5986-5998

MX 2 is a novel regulator of cell cycle in melanoma cells

*Pigment Cell & Melanoma Research* 2019; 33(3):446-457